The centrosomal protein tax1 binding protein 2 is a novel tumor suppressor in hepatocellular carcinoma regulated by cyclin-dependent kinase 2

Hepatology

Volumn 56, Issue 5, 2012, Pages 1770-1781

  Lai, Wai Lung ^a   Hung, Wing Yan ^a   Wong, Leo Lap Yan ^a   Zhou, Yuan ^a   Leong, Veronica Yee Law ^a   Lee, Joyce Man Fong ^a   Ng, Irene Oi Lin ^a,c   Jin, Dong Yan ^b,c   Ching, Yick Pang ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BINDING PROTEIN; CYCLIN DEPENDENT KINASE 1; SYNAPTOPHYSIN; TAX1 BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENICITY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

CARCINOMA, HEPATOCELLULAR; CENTROSOME; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HEP G2 CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; PHOSPHORYLATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84868210910     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25851     Document Type: Article

References (14)

1. Spangenberg HC, Thimme R, Blum HE. Targeted therapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2009; 6: 423-432.
2. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002; 31: 339-346.
3. Nigg EA, Stearns T. The centrosome cycle: centriole biogenesis, duplication, and inherent asymmetries. Nat Cell Biol 2011; 13: 1154-1160.
4. Chi YH, Jeang KT. Aneuploidy and cancer. J Cell Biochem 2007; 102: 531-538.
5. Ching YP, Chan SF, Jeang KT, Jin DY. The retroviral oncoprotein Tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication. Nat Cell Biol 2006; 8: 717-724.
6. Mayor T, Stierhof YD, Tanaka K, Fry AM, Nigg EA. The centrosomal protein C-Nap1 is required for cell cycle-regulated centrosome cohesion. J Cell Biol 2000; 151: 837-846.
7. Lavin MF, Gueven N. The complexity of p53 stabilization and activation. Cell Death Differ 2006; 13: 941-950.
8. Mikule K, Delaval B, Kaldis P, Jurcyzk A, Hergert P, Doxsey S. Loss of centrosome integrity induces p38-p53-p21-dependent G1-S arrest. Nat Cell Biol 2007; 9: 160-170.
9. Srsen V, Gnadt N, Dammermann A, Merdes A. Inhibition of centrosome protein assembly leads to p53-dependent exit from the cell cycle. J Cell Biol 2006; 174: 625-630.
10. Li KK, Ng IO, Fan ST, Albrecht JH, Yamashita K, Poon RY. Activation of cyclin-dependent kinases CDC2 and CDK2 in hepatocellular carcinoma. Liver 2002; 22: 259-268.
11. Koshikawa K, Nomoto S, Yamashita K, Ishigure K, Takeda S, Nakao A. Allelic imbalance at 1p36 in the pathogenesis of human hepatocellular carcinoma. Hepatogastroenterology 2004; 51: 186-191.
12. Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 2010; 1802: 396-405.
13. Seitz SJ, Schleithoff ES, Koch A, Schuster A, Teufel A, Staib F, et al. Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway. Int J Cancer 2010; 126: 2049-2066.
14. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, 3rd, Hurov KE, Luo J, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007; 316: 1160-1166.